Fibroblast growth factor 21 serum concentrations in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2)

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2018-08, Vol.275, p.e151-e151
Main Authors: Walus-miarka, M., Idzior-Walus, B., Kapusta, M., Trojak, A., Miarka, P., Malecki, M.T.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2018.06.449